BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31758015)

  • 1. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
    Koehne E; Kreidenweiss A; Zoleko Manego R; McCall M; Mombo-Ngoma G; Mackwitz MKW; Hansen FK; Held J
    Sci Rep; 2019 Nov; 9(1):17336. PubMed ID: 31758015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    Diedrich D; Stenzel K; Hesping E; Antonova-Koch Y; Gebru T; Duffy S; Fisher G; Schöler A; Meister S; Kurz T; Avery VM; Winzeler EA; Held J; Andrews KT; Hansen FK
    Eur J Med Chem; 2018 Oct; 158():801-813. PubMed ID: 30245402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
    Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
    Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
    Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
    Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
    Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Anticancer Drugs To Tackle Malaria.
    Le Govic Y; Houzé S; Papon N
    ChemMedChem; 2021 Jul; 16(14):2192-2194. PubMed ID: 33931947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.
    Sumanadasa SD; Goodman CD; Lucke AJ; Skinner-Adams T; Sahama I; Haque A; Do TA; McFadden GI; Fairlie DP; Andrews KT
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3849-56. PubMed ID: 22508312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
    Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
    ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.
    Nardella F; Halby L; Dobrescu I; Viluma J; Bon C; Claes A; Cadet-Daniel V; Tafit A; Roesch C; Hammam E; Erdmann D; Mairet-Khedim M; Peronet R; Mecheri S; Witkowski B; Scherf A; Arimondo PB
    J Med Chem; 2021 Jul; 64(14):10403-10417. PubMed ID: 34185525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
    Ndong JM; Atteke C; Aubouy A; Bakary M; Lébibi J; Deloron P
    Trop Med Int Health; 2003 Jan; 8(1):25-9. PubMed ID: 12535246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon.
    Held J; Soomro SA; Kremsner PG; Jansen FH; Mordmüller B
    Int J Antimicrob Agents; 2011 May; 37(5):485-8. PubMed ID: 21392942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.
    Agbor-Enoh S; Seudieu C; Davidson E; Dritschilo A; Jung M
    Antimicrob Agents Chemother; 2009 May; 53(5):1727-34. PubMed ID: 19223622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity.
    Mackwitz MKW; Hesping E; Antonova-Koch Y; Diedrich D; Woldearegai TG; Skinner-Adams T; Clarke M; Schöler A; Limbach L; Kurz T; Winzeler EA; Held J; Andrews KT; Hansen FK
    ChemMedChem; 2019 May; 14(9):912-926. PubMed ID: 30664827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
    Kumar A; Dhar SK; Subbarao N
    J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
    Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
    ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
    Dawood WA; Fisher GM; Kinnen FJM; Anzenhofer C; Skinner-Adams T; Alves Avelar L; Asfaha Y; Kurz T; Andrews KT
    Exp Parasitol; 2024 Mar; 258():108716. PubMed ID: 38340779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antimalarial activity of histone deacetylase inhibitor analogues.
    Andrews KT; Tran TN; Lucke AJ; Kahnberg P; Le GT; Boyle GM; Gardiner DL; Skinner-Adams TS; Fairlie DP
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1454-61. PubMed ID: 18212103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.